Managing Metastatic Extrapulmonary Neuroendocrine Carcinoma After First-Line Treatment.
Saved in:
| Title: | Managing Metastatic Extrapulmonary Neuroendocrine Carcinoma After First-Line Treatment. |
|---|---|
| Authors: | Andreatos N; Division of Medical Oncology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA., McGarrah PW; Division of Medical Oncology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA., Sonbol MB; Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, AZ, USA., Starr JS; Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, FL, USA., Capdevila J; Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Universitat Autònoma de Barcelona, Barcelona, Spain., Sorbye H; Department of Oncology, Haukeland University Hospital, Bergen, Norway.; Department of Clinical Science, University of Bergen, Bergen, Norway., Halfdanarson TR; Division of Medical Oncology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA. halfdanarson.thorvardur@mayo.edu. |
| Source: | Current oncology reports [Curr Oncol Rep] 2023 Oct; Vol. 25 (10), pp. 1127-1139. Date of Electronic Publication: 2023 Aug 22. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Current Science Country of Publication: United States NLM ID: 100888967 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-6269 (Electronic) Linking ISSN: 15233790 NLM ISO Abbreviation: Curr Oncol Rep Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 37606874 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Managing Metastatic Extrapulmonary Neuroendocrine Carcinoma After First-Line Treatment. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Andreatos+N%22">Andreatos N</searchLink>; Division of Medical Oncology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.<br /><searchLink fieldCode="AU" term="%22McGarrah+PW%22">McGarrah PW</searchLink>; Division of Medical Oncology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.<br /><searchLink fieldCode="AU" term="%22Sonbol+MB%22">Sonbol MB</searchLink>; Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, AZ, USA.<br /><searchLink fieldCode="AU" term="%22Starr+JS%22">Starr JS</searchLink>; Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, FL, USA.<br /><searchLink fieldCode="AU" term="%22Capdevila+J%22">Capdevila J</searchLink>; Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Universitat Autònoma de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Sorbye+H%22">Sorbye H</searchLink>; Department of Oncology, Haukeland University Hospital, Bergen, Norway.; Department of Clinical Science, University of Bergen, Bergen, Norway.<br /><searchLink fieldCode="AU" term="%22Halfdanarson+TR%22">Halfdanarson TR</searchLink>; Division of Medical Oncology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA. halfdanarson.thorvardur@mayo.edu. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22100888967%22">Current oncology reports</searchLink> [Curr Oncol Rep] 2023 Oct; Vol. 25 (10), pp. 1127-1139. <i>Date of Electronic Publication: </i>2023 Aug 22. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Review – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Current+Science%22">Current Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>100888967 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1534-6269 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215233790%22">15233790 </searchLink><i>NLM ISO Abbreviation: </i>Curr Oncol Rep <i>Subsets: </i>MEDLINE; In Process |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37606874 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s11912-023-01438-w Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1127 Titles: – TitleFull: Managing Metastatic Extrapulmonary Neuroendocrine Carcinoma After First-Line Treatment. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Andreatos N – PersonEntity: Name: NameFull: McGarrah PW – PersonEntity: Name: NameFull: Sonbol MB – PersonEntity: Name: NameFull: Starr JS – PersonEntity: Name: NameFull: Capdevila J – PersonEntity: Name: NameFull: Sorbye H – PersonEntity: Name: NameFull: Halfdanarson TR IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 10 Text: 2023 Oct Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 1534-6269 Numbering: – Type: volume Value: 25 – Type: issue Value: 10 Titles: – TitleFull: Current oncology reports Type: main |
| ResultId | 1 |